Skip to content
Screener

Asset Entities ASST Q2 2025 earnings

Reported August 5, 2025 · Before market open

Revenue$173.3K
EPS-$0.17

Next report

Nov 9, 2026 (in 2 months)
Revenue estimate$3.0M
EPS estimate-$0.23

Financials

Q2 2025

Income statement

See full
Revenue$173.3K+86.4%
Operating income-$3.7M-114%
Net income-$8.9M-51.2%
EPS (diluted)-$3.86-566%

Balance sheet

See full
Cash & equivalents$12.6M+555%
Total equity$10.7M+98.6%
Total assets$3.3M+33.4%

Cash flow

See full
Operating cash flow-$4.4M-246%

Valuation & ratios

Valuation

as of 06/30/25
See full
Market cap$76.65M—
P/S100.9×—

Profitability

See full
Operating margin-2,562.2%+4,297pp
Net margin-3,099.2%-422pp

Returns & leverage

See full
Return on equity-292.2%+47.8pp
Current ratio4.7×-1.3×

Segments

By segment

See full
Asset Management$1.5M—
Corporate & Other$23.0K—
Medical Device-—

By product

See full
Investment advisory fees$1.5M—
Medical device revenues-—

FAQ

When did Asset Entities report Q2 2025 earnings?
Asset Entities (ASST) reported Q2 2025 earnings on August 5, 2025 before market open.
What were Asset Entities's Q2 2025 revenue and EPS?
Asset Entities reported revenue of $173.3K and eps of $-0.17 for Q2 2025.
How did Asset Entities's Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 86.4% from $93.0K a year earlier and eps grew 70.7% from $-0.58.
Where can I find Asset Entities's Q2 2025 SEC filings?
You can read the 10-Q periodic report (0001213900-25-071724) directly on SEC EDGAR. The filing index links above go to sec.gov.